Conference
716 A randomized phase II window of opportunity clinical trial of PD-1 +/- IL-4 inhibition in early-stage ER+ HER2- breast cancer
Authors
Arnaout A; Hopkins M; Saldana O; Ozuna VL; Talebian V; Jain D; Pond G; Petrocelli T; Spears M
Pagination
pp. a818-a818
Publisher
BMJ
Publication Date
November 1, 2024
DOI
10.1136/jitc-2024-sitc2024.0716
Name of conference
Regular and Young Investigator Award Abstracts